Built in Bangladesh,
for Bangladesh.

The starting belief.

Agro Care began in 2012 with a single shipment of imported veterinary minerals and a thesis: that Bangladesh's animal-health market was being served by formulations designed elsewhere — and those formulations were good, but they weren't tuned for our feed, our seasons, or our cattle.

The plan was modest. We would import the best available products, label them honestly, and let our dealer network do the rest. That plan changed within eighteen months.

A research partnership changes the plan.

In 2014 we approached the Chattogram Veterinary and Animal Sciences University — Bangladesh's leading veterinary research institution — with a simple question: could we co-develop formulations that started from local feed conditions rather than adapting global SKUs?

The CVASU faculty had been studying micronutrient gaps in Bangladeshi feed for years. We had the manufacturing intent, the capital to fund trials, and a dealer network ready to distribute. The first proprietary formulation arrived in 2016 as Vita Feed Gold.

The audits, then the scale.

The work after 2016 was discipline, not scale. The manufacturing facility was audited and certified to ISO 9001:2015 in 2018; the Department of Livestock Services registered our first dozen products under Category 1 the same year; GMP followed in 2021 after a full pharmaceutical-grade audit. The scope of each audit is published on the Certifications page.

We could have grown faster by importing more SKUs and undercutting on price. We chose not to. The dealers we work with carry one Agro Care product per district — local stock, local advice, transparent pricing.

The biscuit — and what comes next.

In 2024 we launched Vita Feed Biscuit: the first cattle biscuit ever produced in Bangladesh. It is the same nutritional intent as Vita Feed Gold, pressed into a single shelf-stable pellet for the twelve-to-eighteen-month fattening window where dosing accuracy matters most.

A CVASU field trial across 96 animals through the second half of 2024 recorded a mean daily weight gain 18.4% above control. The trial protocol, the data, and the analysis are available on request.

The next decade is more of the same: research-led formulation, audited manufacturing, local distribution — and the discipline to refuse the shortcuts that would erode any of the three.